Repurposed Drug & Supplement Protocols by Dr. William Makis
Pioneering targeted integrative care using evidence-informed repurposed medications (Ivermectin, Fenbendazole, Mebendazole, Hydroxychloroquine) paired with high-potency supplement stacks to target cancer bioenergetics and cellular resilience.
The Fenbendazole & Joe Tippens Protocols
Disrupting tumor microtubule polymerization and cellular glucose transport through structured antiparasitic cycling, fat-solubility enhancement, and synergistic antioxidant stacks.
Spike Protein & Vaccine Detoxification
Medically supervised detox programs combining Nattokinase, Bromelain, NAC, Ivermectin, and targeted organ-protective nutraceuticals to dissolve protein aggregates and support microvascular recovery.
Targeted Supplement Stacks for Protocol Support
High-potency Curcumin, Quercetin, Zinc, Vitamin D3/K2, Berberine, and TUDCA specifically formulated to optimize protocol tolerance, liver health, and anti-inflammatory pathways.
Repurposed Medications & Targeted Supplement Care
Medically Supervised Antiparasitics, Metabolic Modulators & High-Potency Nutraceuticals
DR. WILLIAM MAKIS' CLINICAL APPROACH
Targeting cancer cell metabolism, microtubule dynamics, and stem cell pathways using well-studied repurposed compounds.
Repurposed medications such as Ivermectin, Fenbendazole, Mebendazole, and Hydroxychloroquine have demonstrated significant anti-tumor and immunomodulatory mechanisms in preclinical and clinical literature.
By combining structured medication cycling with targeted organ support (TUDCA, NAC, Milk Thistle) and synergistic nutraceuticals (Curcumin, Quercetin, Berberine), Dr. William Makis constructs personalized treatment roadmaps designed for optimal biological efficacy.
Repurposed Drug Synergy Matrix
Combining antiparasitic compounds (Ivermectin, Fenbendazole, Mebendazole) with metabolic regulators and cellular detoxification agents for multi-pathway cancer targeting.
ANTIPARASITIC & ANTI-MITOTIC
Benzimidazoles & Avermectins
Fenbendazole, Mebendazole, and Ivermectin target tumor tubulin assembly, disrupt glucose utilization (GLUT-1), and inhibit Wnt/β-catenin signaling in resistant cancer cell populations.
METABOLIC MODULATION
AMPK & Glycolysis Regulation
Utilizing Hydroxychloroquine, Berberine, and Metformin to disrupt tumor autophagic rescue mechanisms, suppress lactate production, and starve metabolic cancer pathways.
DETOX & ORGAN PROTECTION
Spike Detox & Hepatic Shield
Targeted proteolytic enzymes (Nattokinase, Bromelain) and hepatoprotective compounds (TUDCA, NAC, Glutathione) prevent Herxheimer reactions and protect liver function during active protocol cycling.
CLINICAL INSIGHTS & PRESENTATIONS
Watch Dr. William Makis, MD
Watch recent video shorts and clinical discussions with Dr. William Makis on repurposed medications, targeted cancer protocols, and spike protein detoxification.
PRACTITIONER-GRADE FORMULATIONS
Targeted Protocol Supplements
High-purity, bioavailable nutraceuticals specifically selected by Dr. William Makis to enhance protocol synergy and organ protection.
Ivermectin + Mebendazole : Parasites
$400.00
Ivermectin is an antiparasitic medication that has been used in humans since the 1970’s and has continually proven to be safe and effective. It is used to treat parasitic infections inside and outside the body. Mebendazole is a different type of antiparasitic medication best known for treating infections caused by worms.
Menbendazole
$540.00
Mebendazole 250mg Mebendazole is a trusted prescription anti-parasitic that works by stopping intestinal worms from absorbing the nutrients they need to survive. Your body then clears the infection naturally. Each bottle contains 90 compounded capsules (250mg each), giving you a practical treatment options.
PHYSICIAN & RESEARCH LEAD
Meet Dr. William Makis, MD
MD, FRCPC | Repurposed Medications & Integrative Oncology
Dr. William Makis, MD, FRCPC is a Canadian physician and medical researcher specializing in nuclear medicine, radiology, and targeted cancer therapeutics. With over 100 peer-reviewed medical publications, Dr. Makis is an internationally recognized pioneer in repurposed medication protocols for oncology and spike protein detoxification.
Through comprehensive clinical consultations, Dr. Makis evaluates individual medical histories, pathology reports, and biomarker data to construct evidence-informed repurposed drug and supplement roadmaps.
Read Dr. Makis' Full Bio & ResearchRESEARCH & MEDICAL INSIGHTS
Latest Blog Posts & Articles
🚨 #BREAKING: New PubMed peer reviewed study shows 84% of cancer patients...
🚨 #BREAKING: New PubMed peer reviewed study shows 84% of cancer patients taking ivermectin + mebendazole disappeared, shrunk, o...
🎗 A brain tumor nearly vanished in just 5 days after one dose of a break...
🎗 A brain tumor nearly vanished in just 5 days after one dose of a breakthrough treatment.Experts say this may be the beginning...
We found 84% of cancer patients taking ivermectin + mebendazole declared...
We found 84% of cancer patients taking ivermectin + mebendazole declared their cancer had COMPLETELY DISAPPEARED, SHRUNK, or ST...
COMMON QUESTIONS
Frequently Asked Questions
Clear answers regarding oncologist collaboration, telemedicine availability, record requirements, timeline, and protocol personalization.
START YOUR PERSONALIZED PROTOCOL
Ready to Explore Repurposed Drug Protocols with Dr. William Makis?
Schedule an in-person appointment in San Francisco, CA or request a secure telemedicine record review to receive your individualized treatment roadmap.